TSE: 7061 - Japan Hospice Holdings Inc.

Yield per half year: +5.3%
Dividend yield: +1.09%
Sector: Healthcare

Japan Hospice Holdings Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
6/10
26.49 110.39 -76% 67.6 -60.82%
P/S 1.83 74.99 -97.56%
P/BV 6.71 70.27 -90.45%
P/FCF -28.48 79.2 -135.96%
Ev/Ebitda 15.97 16.85 -5.27%
Ev/S 2.74 80.73 -96.6%
Ev/FCF -31.29 24.73 -226.53%
E/P 0.0277 -0.1555 -117.82%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
5/10
17.17 -144.44 -111.89% 15.62 +9.98%
ROE 25.33 -9.24 -374.02%
ROA 4.5 -9.69 -146.42%
ROIC 0 9.09 -100%
ROS 6.91 -211.07 -103.27%
ROCE 47.68 6.03 690.58%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
7/10
1.78 -1.04 -270.97% 4.65 -61.67%
Nеt Debt/Ebitda 5.31 12.51 -57.51%
Debt/Ratio 0.1993 0.1401 42.23%
Debt/Equity 0.4133 40.14 -98.97%
Debt/Net Income 4.43 -1.96 -326.08%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
2.73/10
1.09 2.65 -58.93% 1.09 -0.0107%
Number of years of dividend growth 0 1.28 -100%
DSI 1 0.7376 35.58%
Average dividend growth 0 -18.51 -100%
Average percentage for 5 years 1.09 1.9 -42.7%
Average percentage for payments 240.91 32.83 633.86%
Difference from average difference in sector -1.56

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
135.61 87.09 55.71%
Growth impulse Ebitda in 5 years 185.36 69.14 168.09%
Growth impulse Net Income in 5 years 128.9 31.67 307.01%
Growth impulse FCF in 5 years -451.02 -20.71 2077.79%
Growth impulse EPS in 5 years 115.73 -36.16 -420.05%
IP Score
5.43/10

Similar companies

Takeda Pharmaceutical Company Limited

HOYA Corporation

Daiichi Sankyo Company, Limited

Chugai Pharmaceutical Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription